DEPRESSION NORMAL MOOD RECOVERY OR REMISSION EPISODE OF DEPRESSION TIME 6 - 24 months 5-1 Stahl S M,...

66
DEPRESSION NORMAL MOOD RECOVERY OR REMISSION EPISODE OF DEPRESSION EPISODE OF DEPRESSION TIME 6 - 24 months 5-1 Stahl S M, Essential Psychopha (2000)

Transcript of DEPRESSION NORMAL MOOD RECOVERY OR REMISSION EPISODE OF DEPRESSION TIME 6 - 24 months 5-1 Stahl S M,...

DEPRESSION

NORMAL MOOD

RECOVERY OR REMISSION

EPISODE OF DEPRESSIONEPISODE OF DEPRESSION

TIME6 - 24 months

5-1 Stahl S M, Essential Psychopharmacology (2000)

DEPRESSION

NORMAL MOOD

RESPONSE

RESPONSE

5-2 Stahl S M, Essential Psychopharmacology (2000)

acute 6 - 12 weeks

continuation4-9 months

maintenance1 or more years

REMISSION

RECOVERY

DEPRESSION

NORMAL MOOD

100%

5-3 Stahl S M, Essential Psychopharmacology (2000)

TIME

5-4 Stahl S M, Essential Psychopharmacology (2000)

acute 6 - 12 weeks

continuation4-9 months

maintenance1 or more years

TIME

DEPRESSION

NORMAL MOOD RELAPSE RECURRENCE

5-5 Stahl S M, Essential Psychopharmacology (2000)

DEPRESSION

NORMAL MOOD

MANIA

HYPOMANIA

MIXED EPISODE

12 months

DEPRESSION

NORMAL MOOD

RAPID CYCLINGRAPID CYCLING

5-6 Stahl S M, Essential Psychopharmacology (2000)

2+ years

DEPRESSION

NORMAL MOOD

DYSTHYMIADYSTHYMIA

5-7 Stahl S M, Essential Psychopharmacology (2000)

6 - 24 months2+ years

DEPRESSION

NORMAL MOOD

DYSTHYMIA PARTIAL RECOVERY

DOUBLE DEPRESSIONDOUBLE DEPRESSION

5-8 Stahl S M, Essential Psychopharmacology (2000)

5-9 Stahl S M, Essential Psychopharmacology (2000)

8 weeks

DEPRESSION

NORMAL MOOD

67% RESPONDERS

MEDICATIONMEDICATION

medication started

33% NON-RESPONDERS

5-10 Stahl S M, Essential Psychopharmacology (2000)

8 weeks

DEPRESSION

NORMAL MOOD

33% RESPONDERS

PLACEBOPLACEBO

placebo started

67% NON-RESPONDERS

5-11 Stahl S M, Essential Psychopharmacology (2000)

DEPRESSION

NORMAL MOOD

50% continue response

PLACEBO PLACEBO SUBSTITUTIONSUBSTITUTION

antidepressant treatment

placebo

50% relapse

5-12 Stahl S M, Essential Psychopharmacology (2000)

DEPRESSION

NORMAL MOOD

90% continue response

DRUG DRUG CONTINUATIONCONTINUATION

antidepressant treatment

10% relapse

MAO enzyme destroying neurotransmitter

monoamine neurotransmitter

NORMAL STATE -- no depression

MONOAMINE HYPOTHESIS

5-13 5-14

Stahl S M, Essential Psychopharmacology (2000)

DEPRESSION -- caused by neurotransmitter deficiency

Increase in neurotransmitters causes return to normal state

MAO inhibitor blocks the enzyme from destroying monoamine neurotransmitter

reuptake pump blocked by antidepressant

5-15 5-16

Stahl S M, Essential Psychopharmacology (2000)

NE (norepinephrine)

tyrosine transporter

TYR

TOH

DOPA

DDC DA

DBH

NOREPINEPHRINE IS PRODUCED

5-17 Stahl S M, Essential Psychopharmacology (2000)

NOREPINEPHRINE IS DESTROYED

COMT destroys NEnorepinephrine

transporter

MAO

5-18 Stahl S M, Essential Psychopharmacology (2000)

NOREPINEPHRINE RECEPTORS

presynaptic alpha 2 autoreceptor

postsynaptic alpha 2

receptorpostsynaptic beta 1 receptor

alpha 1 receptor

5-19 Stahl S M, Essential Psychopharmacology (2000)

terminal alpha 2 autoreceptor

somatodendritic alpha 2

autoreceptor

5-20 Stahl S M, Essential Psychopharmacology (2000)

NE occupying somatodendritic autoreceptor causes a decrease in firing and a decrease of NE release

5-21 Stahl S M, Essential Psychopharmacology (2000)

NE

NE occupying terminal alpha 2 receptor halts release of NE

5-22 Stahl S M, Essential Psychopharmacology (2000)

NE

Norepinephrine Pathways

Locus Coeruleus

5-23 Stahl S M, Essential Psychopharmacology (2000)

beta 1 receptor

5-24 Stahl S M, Essential Psychopharmacology (2000)

DepressionFrontal 1

alpha 2 receptor

Frontal 2 Attention

5-25 Stahl S M, Essential Psychopharmacology (2000)

5-26 Stahl S M, Essential Psychopharmacology (2000)

Limbic

EmotionsAgitationEnergy Level

5-27 Stahl S M, Essential Psychopharmacology (2000)

Cerebellum Tremor

5-28 Stahl S M, Essential Psychopharmacology (2000)

Spinal Cord Blood Pressure

5-29 Stahl S M, Essential Psychopharmacology (2000)

Heart Tachycardia

5--30 Stahl S M, Essential Psychopharmacology (2000)

Bladder Urinary Retention

tyrosine transporter

TOH

TYR

DOPA

DDC

DA (Dopamine)

DOPAMINE IS PRODUCED

5--31 Stahl S M, Essential Psychopharmacology (2000)

COMT destroys NE

dopamine transporter

MAO

DOPAMINE IS DESTROYED

5--32 Stahl S M, Essential Psychopharmacology (2000)

DOPAMINE RECEPTORS

presynaptic autorecptor

D1 D2 D3 D4 D5

dopamine transporter

5--33 Stahl S M, Essential Psychopharmacology (2000)

5HT (Serotonin)

SEROTONIN IS PRODUCEDtryptophan transporter

TRY-OH

5HTP

AAADC

Tryptophan

5--34 Stahl S M, Essential Psychopharmacology (2000)

serotonin transporter

MAO

SEROTONIN IS DESTROYED

5--35 Stahl S M, Essential Psychopharmacology (2000)

SEROTONIN RECEPTORS

alpha 2 hetero receptor

5HT1D autoreceptor

5HT1A

serotonin transporter

5HT2A5HT2C

5HT3 5HT45HTX

5HTY

5HTZ

5--36 Stahl S M, Essential Psychopharmacology (2000)

5--37 5-38

Stahl S M, Essential Psychopharmacology (2000)

5HT1D

5--39 5-40

Stahl S M, Essential Psychopharmacology (2000)

5--41 Stahl S M, Essential Psychopharmacology (2000)

5--42 Stahl S M, Essential Psychopharmacology (2000)

norepinephrine

serotonin

alpha 2 hetero receptor

serotonin neuron

5--43 Stahl S M, Essential Psychopharmacology (2000)

alpha 2 hetero receptor

serotonin neuron

5--44 Stahl S M, Essential Psychopharmacology (2000)

norepinephrine

serotonin

alpha 1 receptor

5--45 Stahl S M, Essential Psychopharmacology (2000)

norepinephrine

serotonin

alpha 1 receptor

5--46 Stahl S M, Essential Psychopharmacology (2000)

brake

accelerator

Locus Coeruleus

NE-5HT Interactions

5--47 Stahl S M, Essential Psychopharmacology (2000)

serotonin neuron

presynaptic alpha 2 autoreceptor

postsynaptic alpha 2 hetero receptor

presynaptic alpha 2 autoreceptor alpha 1

receptor

norepinephrine neuron

5--48 Stahl S M, Essential Psychopharmacology (2000)

5HT accelerator

5HT brake

5HT2A

5--49

5-50

Stahl S M, Essential Psychopharmacology (2000)

Serotonin Pathways

Raphe Nucleus

5--51 Stahl S M, Essential Psychopharmacology (2000)

5--52 Stahl S M, Essential Psychopharmacology (2000)

Frontal Cortex Mood

5--53 Stahl S M, Essential Psychopharmacology (2000)

Basal Ganglia OCDAkathisia/Agitation

5--54 Stahl S M, Essential Psychopharmacology (2000)

Limbic Anxiety

5--55 Stahl S M, Essential Psychopharmacology (2000)

Hypothalamus Appetite/bulimia

5--56 Stahl S M, Essential Psychopharmacology (2000)

Sleep Centers Insomnia

5--57 Stahl S M, Essential Psychopharmacology (2000)

Spinal Cord Sexual Dysfunction

5--58 Stahl S M, Essential Psychopharmacology (2000)

Brainstem Vomiting Center

Nausea and vomiting

5--59 Stahl S M, Essential Psychopharmacology (2000)

Gut GI cramps/Diarrhea

Monoamine Receptor Hypothesis of DepressionMonoamine Receptor Hypothesis of Depression

Normal functioning

Decrease in NT

Receptors up-regulate due to lack of NT

5--60 5-61 6-62

Stahl S M, Essential Psychopharmacology (2000)

5--63 Stahl S M, Essential Psychopharmacology (2000)

BDNF gene

StressStress

Stress

BDNF

5--64 Stahl S M, Essential Psychopharmacology (2000)

Apoptosis

substance P release

pain and swelling

substance P release

5--65 Stahl S M, Essential Psychopharmacology (2000)

= substance P

hypothalamus

amydala and limbic areas

dopamine centers norepinephrine

centers

Neurokinin Hypothesis of Emotional Malfunctioning Corollary: Blockng the Appropriate Neurokinin

Receptor will Reduce Emotional Distress

5--66 Stahl S M, Essential Psychopharmacology (2000)

substance P

Neurokinin A (NK-A)

Neurokinin B (NK-B)

Arg Pro Lys Gln Gln Phe Phe Gly Leu Met NH2

Gly Leu Met NH2

Gly Leu Met NH2

Val

Val

SerAspThrLysHis

Asp PheHisMetAsp

5--67 Stahl S M, Essential Psychopharmacology (2000)

PPT-A gene

PPT-A mRNA

signal peptidase

endoplasmic reticulum

converting enzyme

substance P

NK-1 receptor

5--68 Stahl S M, Essential Psychopharmacology (2000)

PPT-A spliced mRNA

PPT-A protein

PT-A

PPT-A gene

PPT-A mRNA

signal peptidase

endoplasmic reticulum

converting enzyme

substance P

NK-1 receptor

5--69 Stahl S M, Essential Psychopharmacology (2000)

PPT-A spliced mRNA

PPT-A protein

PT-A

PPT-A gene

PPT-A mRNA

signal peptidase

endoplasmic reticulum

converting enzyme

substance P

NK-1 receptor

PPT-A spliced mRNA

5--70 Stahl S M, Essential Psychopharmacology (2000)

PPT-A protein

PT-A

PPT-A gene

PPT-A mRNA

signal peptidase

endoplasmic reticulum

converting enzyme

NK-A

NK-2 receptor

5--71 Stahl S M, Essential Psychopharmacology (2000)

PPT-A spliced mRNA

PPT-A protein

PT-A

PPT-A gene

PPT-A mRNA

signal peptidase

endoplasmic reticulum

converting enzyme

NK-A

NK-2 receptor

PPT-A spliced mRNA

5--72 Stahl S M, Essential Psychopharmacology (2000)

PPT-A protein

PT-A

PPT-B gene

PPT-B mRNA

PPT-B protein

signal peptidase

endoplasmic reticulum

PT-B

converting enzyme

NK-B

NK-3 receptor

PPT-B spliced mRNA

5--73 Stahl S M, Essential Psychopharmacology (2000)